<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Public Health Rep</journal-id><journal-id journal-id-type="iso-abbrev">Public Health Rep</journal-id><journal-id journal-id-type="pmc-domain-id">333</journal-id><journal-id journal-id-type="pmc-domain">pubhealthrep</journal-id><journal-id journal-id-type="publisher-id">PHR</journal-id><journal-title-group><journal-title>Public Health Reports</journal-title></journal-title-group><issn pub-type="ppub">0033-3549</issn><issn pub-type="epub">1468-2877</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10851899</article-id><article-id pub-id-type="pmcid-ver">PMC10851899.1</article-id><article-id pub-id-type="pmcaid">10851899</article-id><article-id pub-id-type="pmcaiid">10851899</article-id><article-id pub-id-type="pmid">37232166</article-id><article-id pub-id-type="doi">10.1177/00333549231170205</article-id><article-id pub-id-type="publisher-id">10.1177_00333549231170205</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Case Study</subject></subj-group></article-categories><title-group><article-title>Large-Scale, Primary Care&#8211;Based Hepatitis C Treatment in an Urban, Medically Underserved Patient Population</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8439-3598</contrib-id><name name-style="western"><surname>Fluker</surname><given-names initials="SA">Shelly-Ann</given-names></name><degrees>MD</degrees><xref rid="aff1-00333549231170205" ref-type="aff">1</xref><xref rid="corresp1-00333549231170205" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Darby</surname><given-names initials="R">Rapheisha</given-names></name><degrees>MPH</degrees><xref rid="aff2-00333549231170205" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McDaniel</surname><given-names initials="K">Kathryn</given-names></name><degrees>PharmD</degrees><xref rid="aff3-00333549231170205" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Quairoli</surname><given-names initials="K">Kristi</given-names></name><degrees>PharmD</degrees><xref rid="aff3-00333549231170205" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5078-8372</contrib-id><name name-style="western"><surname>Mbonu</surname><given-names initials="C">Collins</given-names></name><degrees>MD</degrees><xref rid="aff1-00333549231170205" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kilakkathi</surname><given-names initials="S">Sindhu</given-names></name><degrees>MD</degrees><xref rid="aff1-00333549231170205" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Koumtouzoua</surname><given-names initials="S">Sarah</given-names></name><degrees>MD</degrees><xref rid="aff1-00333549231170205" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jagannathan</surname><given-names initials="R">Ram</given-names></name><degrees>PhD</degrees><xref rid="aff4-00333549231170205" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miller</surname><given-names initials="LS">Lesley S.</given-names></name><degrees>MD</degrees><xref rid="aff1-00333549231170205" ref-type="aff">1</xref></contrib></contrib-group><aff id="aff1-00333549231170205"><label>1</label>Division of General Internal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA</aff><aff id="aff2-00333549231170205"><label>2</label>Grady Liver Clinic, Grady Health System, Atlanta, GA, USA</aff><aff id="aff3-00333549231170205"><label>3</label>Department of Pharmacy, Grady Health System, Atlanta, GA, USA</aff><aff id="aff4-00333549231170205"><label>4</label>Division of Hospital Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA USA</aff><author-notes><corresp id="corresp1-00333549231170205">Shelly-Ann Fluker, MD, Emory University School of Medicine, Department of Medicine, Division of General Internal Medicine, Emory Faculty Office Building, 49 Jesse Hill Jr Dr SE, Atlanta, GA 30303, USA. Email: <email>shelly-ann.fluker@emory.edu</email></corresp><fn fn-type="COI-statement"><p>The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Miller receives grant funding through Emory University from Gilead Sciences and consulting fees from AbbVie.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>5</month><year>2023</year></pub-date><pub-date pub-type="collection"><season>Mar-Apr</season><year>2024</year></pub-date><volume>139</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">455453</issue-id><fpage>163</fpage><lpage>168</lpage><pub-history><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-01 00:25:24.073"><day>01</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023, Association of Schools and Programs of Public Health</copyright-statement><copyright-year>2023</copyright-year><copyright-holder content-type="society">US Surgeon General&#8217;s Office</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_00333549231170205.pdf"/><abstract><p>Hepatitis C virus (HCV) infection is a critical public health concern in the United States. HCV is highly curable, but access to care is limited for many patients. Primary care models can expand access to HCV care. The Grady Liver Clinic (GLC) is a primary care&#8211;based HCV clinic founded in 2002. During 20 years, using a multidisciplinary team, the GLC expanded its operations in response to advances in HCV screening and treatment. We describe the clinic model, patient population, and treatment outcomes of the clinic from 2015 through 2019. During this period, 2689 patients were seen in the GLC, and 77% (n = 2083) initiated treatment. Eighty-five percent (1779 of 2083) of patients who started treatment completed treatment and were tested for cure, and 1723 (83% of the total treated cohort, 97% of those tested for cure) were cured. Building on a successful primary care&#8211;based treatment model, the GLC dynamically responded to the changes in HCV screening and treatment guidelines, continually increasing access to HCV care. The GLC serves as a model of primary care&#8211;based HCV care that aims to achieve HCV microelimination in a safety-net health system. Our findings support the notion that for the United States to achieve elimination of HCV by 2030, generalists can and should provide HCV care, particularly in medically underserved patient populations.</p></abstract><kwd-group><kwd>hepatitis C</kwd><kwd>primary care</kwd><kwd>underserved population</kwd><kwd>safety-net hospital</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts1</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March/April 2024</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>